Viatris to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Viatris Inc. (NASDAQ: VTRS) announced its participation in two upcoming investor conferences. CEO Michael Goettler and CFO Sanjeev Narula will take part in a fireside chat at the Raymond James 43rd Annual Institutional Investors Conference on March 8 at 3:25 p.m. EST. Additionally, Rajiv Malik, President, and CFO Narula will participate in the Barclays Global Healthcare Conference on March 16 at 10:45 a.m. EST. Live webcasts will be available at investor.viatris.com.

PITTSBURGH, March 1, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will participate in the following investor conferences:

• Chief Executive Officer Michael Goettler and Chief Financial Officer Sanjeev Narula will participate in a fireside chat at the Raymond James 43^rd Annual Institutional Investors Conference on Tuesday, March 8^th at 3:25 p.m. EST.
  
  
• President Rajiv Malik and Chief Financial Officer Sanjeev Narula will participate in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 16^th at 10:45 a.m. EST.

Interested parties can access live webcasts of the events at investor.viatris.com. Archived versions also will be available following the live events and can be accessed at the same location for a limited time. 

About Viatris 
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of over 37,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-participate-in-upcoming-investor-conferences-301493342.html

SOURCE Viatris Inc.

FAQ

What is Viatris' participation in investor conferences?

Viatris will participate in the Raymond James 43rd Annual Institutional Investors Conference on March 8 and the Barclays Global Healthcare Conference on March 16.

When is Viatris scheduled to present at the Raymond James conference?

Viatris is scheduled to present on March 8 at 3:25 p.m. EST.

Who will represent Viatris at the Barclays Global Healthcare Conference?

Rajiv Malik, President, and CFO Sanjeev Narula will represent Viatris at the Barclays Global Healthcare Conference.

Where can I find the live webcast for Viatris' investor events?

Live webcasts for Viatris' investor events can be found at investor.viatris.com.

What time is Viatris' presentation at the Barclays conference?

Viatris' presentation at the Barclays Global Healthcare Conference is scheduled for March 16 at 10:45 a.m. EST.